Quantitative fibroblast acylcarnitine profiles in mitochondrial fatty acid β-oxidation defects: phenotype/metabolite correlations

This publication has 33 references indexed in Scilit:

• Acylcarnitine profiles in fibroblasts from patients with respiratory chain defects can resemble those from patients with mitochondrial fatty acid [beta ]-oxidation disorders
  Metabolism, 2002
• Tandem Mass Spectrometric Analysis for Amino, Organic, and Fatty Acid Disorders in Newborn Dried Blood Spots
  Clinical Chemistry, 2001
• Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency
  The Lancet, 2001
• Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies
  Archives of Disease in Childhood: Fetal & Neonatal, 2001
• Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia
  Acta Paediatrica, 1999
• Clear Correlation of Genotype with Disease Phenotype in Very–Long-Chain Acyl-CoA Dehydrogenase Deficiency
  American Journal of Human Genetics, 1999
• Analysis of Carnitine Esters by Radio-High Performance Liquid Chromatography in Cultured Skin Fibroblasts from Patients with Mitochondrial Fatty Acid Oxidation Disorders
  Pediatric Research, 1998
• Carnitine‐acylcarnitine translocase deficiency ‐ a mild phenotype
  Journal of Inherited Metabolic Disease, 1997
• Inheritance of the S113L mutation within an inbred family with carnitine palmitoyltransferase enzyme deficiency
  Human Genetics, 1996
• Common MCAD mutation in a healthy parent of two affected siblings
  Journal of Inherited Metabolic Disease, 1995